The hyperactive mTORC2-AKT signaling pathway increases the population of CRC Colon cancer stem cells (CSCs), which induces CRC migration and enhances the metastatic dormancy of colorectal cancer (34). This evidence concerns the gene AKT1 and colonic neoplasm.